# Nanoviricides, Inc.: filings

NNVC · NYSE · CIK 1379006 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/nnvc.md) · [Financials](/companies/nnvc/financials.md) · [Filings](/companies/nnvc/filings.md) · [Insiders](/companies/nnvc/insiders.md)

## Reports and events: 210 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 123, 8-K 94, 10-Q 53, CORRESP 26, 424B5 25, 10-K 18, UPLOAD 18, DEF 14A 16, NT 10-Q 15, EFFECT 13, NT 10-K 11, S-3 11, 10-Q/A 9, 10-K/A 8, 424B3 8, 4/A 6, 3 5, 8-K/A 5, S-3/A 5, SC 13G/A 5, D 4, PRE 14A 4, S-1/A 4, DEL AM 3, SC 13G 3, S-1 2, 3/A 1, 424B1 1, 8-A12B 1, CERTNYS 1, DEF 14C 1, DEFA14A 1, DEFR14A 1, DEFR14C 1, FWP 1, POS AM 1, PRE 14C 1, RW 1, S-3MEF 1, S-8 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-08 | 15:28 ET | [DEF 14A](/filings/0001104659-26-114606.md) | Proxy statement, period 2026-11-21 | 0001104659-26-114606 |
| 2026-09-29 | 20:30 ET | [8-K](/filings/0001104659-26-111952.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-111952 |
| 2026-09-28 | 20:30 ET | [10-K](/filings/0001104659-26-111390.md) | Annual report, period 2026-06-30 | 0001104659-26-111390 |
| 2026-07-30 | 10:02 ET | [8-K](/filings/0001104659-26-088393.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-088393 |
| 2026-07-17 | 20:45 ET | [8-K](/filings/0001104659-26-084668.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-084668 |
| 2026-05-21 | 10:01 ET | [8-K](/filings/0001104659-26-064754.md) | 7.01 Regulation FD disclosure | 0001104659-26-064754 |
| 2026-05-20 | 20:30 ET | [8-K](/filings/0001104659-26-064544.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-064544 |
| 2026-05-15 | 00:37 ET | [10-Q](/filings/0001104659-26-061499.md) | Quarterly report, period 2026-03-31 | 0001104659-26-061499 |
| 2026-02-17 | 21:30 ET | [10-Q](/filings/0001104659-26-016476.md) | Quarterly report, period 2025-12-31 | 0001104659-26-016476 |
| 2025-11-26 | 21:30 ET | [8-K](/filings/0001104659-25-116457.md) | 5.07 Shareholder vote results | 0001104659-25-116457 |
| 2025-11-14 | 21:37 ET | [8-K](/filings/0001104659-25-112644.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-112644 |
| 2025-11-14 | 21:32 ET | [10-Q](/filings/0001104659-25-112608.md) | Quarterly report, period 2025-09-30 | 0001104659-25-112608 |
| 2025-10-08 | 23:02 ET | [DEF 14A](/filings/0001104659-25-097618.md) | Proxy statement, period 2025-11-08 | 0001104659-25-097618 |
| 2025-10-01 | 21:07 ET | [8-K](/filings/0001104659-25-095676.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-095676 |
| 2025-09-29 | 20:33 ET | [10-K](/filings/0001104659-25-094527.md) | Annual report, period 2025-06-30 | 0001104659-25-094527 |
| 2025-05-15 | 20:31 ET | [10-Q](/filings/0001410578-25-001336.md) | Quarterly report, period 2025-03-31 | 0001410578-25-001336 |
| 2025-02-14 | 21:30 ET | [10-Q](/filings/0001410578-25-000140.md) | Quarterly report, period 2024-12-31 | 0001410578-25-000140 |
| 2024-12-12 | 22:00 ET | [8-K](/filings/0001104659-24-128066.md) | 5.07 Shareholder vote results | 0001104659-24-128066 |
| 2024-11-14 | 21:30 ET | [10-Q](/filings/0001410578-24-001991.md) | Quarterly report, period 2024-09-30 | 0001410578-24-001991 |
| 2024-10-15 | 20:44 ET | [DEF 14A](/filings/0001104659-24-108620.md) | Proxy statement, period 2024-12-07 | 0001104659-24-108620 |
| 2024-09-27 | 20:15 ET | [10-K](/filings/0001410578-24-001650.md) | Annual report, period 2024-06-30 | 0001410578-24-001650 |
| 2024-08-09 | 20:30 ET | [8-K](/filings/0001104659-24-087828.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-087828 |
| 2024-05-15 | 00:25 ET | [10-Q](/filings/0001410578-24-000843.md) | Quarterly report, period 2024-03-31 | 0001410578-24-000843 |
| 2024-04-05 | 21:25 ET | [8-K](/filings/0001104659-24-044367.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-044367 |
| 2024-02-16 | 21:53 ET | [8-K](/filings/0001104659-24-024973.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-024973 |
| 2024-02-14 | 21:55 ET | [10-Q](/filings/0001410578-24-000048.md) | Quarterly report, period 2023-12-31 | 0001410578-24-000048 |
| 2024-01-19 | 21:44 ET | [8-K](/filings/0001104659-24-005254.md) | 5.07 Shareholder vote results | 0001104659-24-005254 |
| 2023-12-04 | 21:08 ET | [DEF 14A](/filings/0001104659-23-123215.md) | Proxy statement, period 2024-01-13 | 0001104659-23-123215 |
| 2023-11-14 | 21:32 ET | [10-Q](/filings/0001410578-23-002484.md) | Quarterly report, period 2023-09-30 | 0001410578-23-002484 |
| 2023-11-07 | 23:16 ET | [8-K](/filings/0001104659-23-114862.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-114862 |
| 2023-10-13 | 20:30 ET | [10-K](/filings/0001410578-23-002146.md) | Annual report, period 2023-06-30 | 0001410578-23-002146 |
| 2023-09-01 | 20:46 ET | [8-K](/filings/0001104659-23-097802.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-23-097802 |
| 2023-05-25 | 20:31 ET | [8-K](/filings/0001104659-23-064652.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-064652 |
| 2023-05-15 | 20:36 ET | [10-Q](/filings/0001410578-23-001235.md) | Quarterly report, period 2023-03-31 | 0001410578-23-001235 |
| 2023-03-31 | 21:17 ET | [8-K](/filings/0001104659-23-040296.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-23-040296 |
| 2023-02-14 | 22:01 ET | [10-Q](/filings/0001410578-23-000129.md) | Quarterly report, period 2022-12-31 | 0001410578-23-000129 |
| 2023-02-13 | 22:01 ET | [8-K](/filings/0001104659-23-019813.md) | 5.07 Shareholder vote results | 0001104659-23-019813 |
| 2022-12-22 | 22:11 ET | [8-K](/filings/0001104659-22-129595.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001104659-22-129595 |
| 2022-11-15 | 21:30 ET | [DEF 14A](/filings/0001104659-22-119151.md) | Proxy statement, period 2022-12-17 | 0001104659-22-119151 |
| 2022-11-14 | 21:44 ET | [10-Q](/filings/0001410578-22-003398.md) | Quarterly report, period 2022-09-30 | 0001410578-22-003398 |
| 2022-10-13 | 21:12 ET | [10-K](/filings/0001410578-22-002878.md) | Annual report, period 2022-06-30 | 0001410578-22-002878 |
| 2022-10-11 | 20:32 ET | [8-K](/filings/0001104659-22-107752.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-22-107752 |
| 2022-05-16 | 20:35 ET | [10-Q](/filings/0001410578-22-001688.md) | Quarterly report, period 2022-03-31 | 0001410578-22-001688 |
| 2022-02-14 | 21:31 ET | [10-Q](/filings/0001410578-22-000141.md) | Quarterly report, period 2021-12-31 | 0001410578-22-000141 |
| 2021-11-26 | 21:30 ET | [8-K](/filings/0001104659-21-143985.md) | 5.07 Shareholder vote results | 0001104659-21-143985 |
| 2021-11-15 | 21:33 ET | [10-Q](/filings/0001104659-21-139231.md) | Quarterly report, period 2021-09-30 | 0001104659-21-139231 |
| 2021-10-12 | 20:31 ET | [10-K](/filings/0001104659-21-125343.md) | Annual report, period 2021-06-30 | 0001104659-21-125343 |
| 2021-10-12 | 10:15 ET | [DEF 14A](/filings/0001104659-21-124918.md) | Proxy statement, period 2021-11-20 | 0001104659-21-124918 |
| 2021-09-21 | 15:25 ET | [8-K](/filings/0001104659-21-117728.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-117728 |
| 2021-09-15 | 20:36 ET | [8-K](/filings/0001104659-21-115943.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-21-115943 |

Page 1 of 5. [Older](/companies/nnvc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.